These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17381636)

  • 41. Recombinant factor VIIa in trauma patients with the 'triad of death'.
    Mitra B; Cameron PA; Parr MJ; Phillips L
    Injury; 2012 Sep; 43(9):1409-14. PubMed ID: 21345431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
    Negrier C
    J Thromb Haemost; 2003 Mar; 1(3):423-4. PubMed ID: 12871444
    [No Abstract]   [Full Text] [Related]  

  • 43. A clinical review of bleeding dilemmas in trauma.
    Hoyt DB
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):40-3. PubMed ID: 14872420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
    Pernazza F; Olearis A
    Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
    [No Abstract]   [Full Text] [Related]  

  • 45. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A massive transfusion protocol incorporating a higher FFP/RBC ratio is associated with decreased use of recombinant activated factor VII in trauma patients.
    Tan JN; Burke PA; Agarwal SK; Mantilla-Rey N; Quillen K
    Am J Clin Pathol; 2012 Apr; 137(4):566-71. PubMed ID: 22431532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant activated factor VII--"lifesaving or surgeon correcting"?
    Koci J; Dedek T; Havel E; Trlica J
    J Trauma; 2011 Feb; 70(2):523-4; author reply 524-5. PubMed ID: 21307759
    [No Abstract]   [Full Text] [Related]  

  • 48. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
    Grinţescu I; Tulbure D; Mirea L
    Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant activated factor VII for non-hemophiliac bleeding patients.
    Uhlmann EJ; Eby CS
    Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.
    Planinsic RM; van der Meer J; Testa G; Grande L; Candela A; Porte RJ; Ghobrial RM; Isoniemi H; Schelde PB; Erhardtsen E; Klintmalm G; Emre S
    Liver Transpl; 2005 Aug; 11(8):895-900. PubMed ID: 16035081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Oct; 15(10):814-30. PubMed ID: 16176309
    [No Abstract]   [Full Text] [Related]  

  • 55. New developments in massive transfusion in trauma.
    Greer SE; Rhynhart KK; Gupta R; Corwin HL
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):246-50. PubMed ID: 20104173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of off-label recombinant activated factor VII for multiple indications in children.
    Reiter PD; Valuck RJ; Taylor RS
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):233-40. PubMed ID: 17636185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Summaries for patients. A new way to reverse excessive blood thinning from warfarin.
    Ann Intern Med; 2002 Dec; 137(11):I41. PubMed ID: 12459002
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 59. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
    Bartal C; Freedman J; Bowman K; Cusimano M
    J Trauma; 2007 Oct; 63(4):725-32. PubMed ID: 18089997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thromboelastometry to guide recombinant activated factor VII therapy for postoperative refractory intracranial bleeding.
    Hirasaki Y; Suematsu Y; Yasuda T; Tajima K
    Anesth Analg; 2010 Jan; 110(1):261-2. PubMed ID: 20023190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.